5-[9-[[(3S,4S)-3,4-difluoropyrrolidin-1-yl]methyl]-15-fluoro-3,8,10-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2(7),3,5,8,11(16),12,14-octaen-4-yl]-N-methyl-6-[methyl(methylsulfonyl)amino]-2-(4-methylphenyl)-1-benzofuran-3-carboxamide
C38H33F3N6O4S — CID 118595600
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[9-[[(3S,4S)-3,4-difluoropyrrolidin-1-yl]methyl]-15-fluoro-3,8,10-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2(7),3,5,8,11(16),12,14-octaen-4-yl]-N-methyl-6-[methyl(methylsulfonyl)amino]-2-(4-methylphenyl)-1-benzofuran-3-carboxamide
5-[9-[[(3S,4S)-3,4-difluoropyrrolidin-1-yl]methyl]-15-fluoro-3,8,10-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2(7),3,5,8,11(16),12,14-octaen-4-yl]-N-methyl-6-[methyl(methylsulfonyl)amino]-2-(4-methylphenyl)-1-benzofuran-3-carboxamide (PubChem CID 118595600) has the molecular formula C38H33F3N6O4S and a molecular weight of 726.78 g/mol. Its IUPAC name is 5-[9-[[(3S,4S)-3,4-difluoropyrrolidin-1-yl]methyl]-15-fluoro-3,8,10-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2(7),3,5,8,11(16),12,14-octaen-4-yl]-N-methyl-6-[methyl(methylsulfonyl)amino]-2-(4-methylphenyl)-1-benzofuran-3-carboxamide.
Molecular Properties
| Compound Name | 5-[9-[[(3S,4S)-3,4-difluoropyrrolidin-1-yl]methyl]-15-fluoro-3,8,10-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2(7),3,5,8,11(16),12,14-octaen-4-yl]-N-methyl-6-[methyl(methylsulfonyl)amino]-2-(4-methylphenyl)-1-benzofuran-3-carboxamide |
|---|---|
| PubChem CID | 118595600 |
| Molecular Formula | C38H33F3N6O4S |
| Molecular Weight | 726.78 g/mol |
| Exact Mass | 726.22 |
| IUPAC Name | 5-[9-[[(3S,4S)-3,4-difluoropyrrolidin-1-yl]methyl]-15-fluoro-3,8,10-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2(7),3,5,8,11(16),12,14-octaen-4-yl]-N-methyl-6-[methyl(methylsulfonyl)amino]-2-(4-methylphenyl)-1-benzofuran-3-carboxamide |
| SMILES | CNC(=O)c1c(-c2ccc(C)cc2)oc2cc(N(C)S(C)(=O)=O)c(-c3ccc4nc(CN5C[C@H](F)[C@@H](F)C5)n5c6cccc(F)c6cc5c4n3)cc12 |
| InChI | InChI=1S/C38H33F3N6O4S/c1-20-8-10-21(11-9-20)37-35(38(48)42-2)24-14-23(31(16-33(24)51-37)45(3)52(4,49)50)28-12-13-29-36(44-28)32-15-22-25(39)6-5-7-30(22)47(32)34(43-29)19-46-17-26(40)27(41)18-46/h5-16,26-27H,17-19H2,1-4H3,(H,42,48)/t26-,27-/m0/s1 |
| InChIKey | UBVAAAYIICVOPF-SVBPBHIXSA-N |
| XLogP | 6.81 |
| TPSA | 113.05 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 726.78 |
| LogP ≤ 5 | 6.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118595600 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.